JG
FLXN

Jefferies Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Jefferies Group’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,000
Closed -$25K – 2872
2017
Q4 		$25K Buy
+1,000
New +$24.5K ﹤0.01% 2414

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Jefferies Group's FLXN Position: Q4 2019 in Review

Jefferies Group sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 15,179 shares — an estimated $208K sold.

Jefferies Group first reported a position in FLXN in Q2 2015 and held it in 4 quarters. The position peaked at $1.75M in Q4 2017. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

  • Jefferies Group reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 15,179 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $208K.
  • Jefferies Group first reported a position in Flexion Therapeutics, Inc. in Q2 2015 and held it in 4 quarters.
  • Jefferies Group's Flexion Therapeutics, Inc. position peaked at $1.75M in Q4 2017.
  • 133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.